1. Home
  2. TRST vs GERN Comparison

TRST vs GERN Comparison

Compare TRST & GERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TrustCo Bank Corp NY

TRST

TrustCo Bank Corp NY

HOLD

Current Price

$42.41

Market Cap

699.3M

Sector

Finance

ML Signal

HOLD

Logo Geron Corporation

GERN

Geron Corporation

HOLD

Current Price

$1.31

Market Cap

753.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRST
GERN
Founded
1902
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
699.3M
753.3M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
TRST
GERN
Price
$42.41
$1.31
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$3.00
AVG Volume (30 Days)
102.4K
7.7M
Earning Date
01-20-2026
11-05-2025
Dividend Yield
3.58%
N/A
EPS Growth
21.05
N/A
EPS
3.00
N/A
Revenue
$181,464,000.00
$183,403,000.00
Revenue This Year
$13.13
$147.34
Revenue Next Year
N/A
$39.11
P/E Ratio
$14.54
N/A
Revenue Growth
7.63
522.13
52 Week Low
$27.18
$1.04
52 Week High
$43.96
$4.09

Technical Indicators

Market Signals
Indicator
TRST
GERN
Relative Strength Index (RSI) 63.73 63.85
Support Level $41.25 $1.15
Resistance Level $43.96 $1.21
Average True Range (ATR) 1.08 0.05
MACD 0.15 0.02
Stochastic Oscillator 74.07 100.00

Price Performance

Historical Comparison
TRST
GERN

About TRST TrustCo Bank Corp NY

Trustco Bank Corp N Y is a savings and loan holding company. The core part of a business consists of accepting deposits and making loans and investments. It offers a range of both personal and business banking services. The company's product includes savings accounts; retirement accounts; money market account; mortgages; building loans; auto loans and others. The company based on only one business segment, that of community banking. TrustCo lends in the geographic territory of its branch locations in New York, Florida, Massachusetts, New Jersey, and Vermont.

About GERN Geron Corporation

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

Share on Social Networks: